Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...

John Ferguson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...

Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer’s disease. Produced by Roche, Elecsys pTau181 measures the concentration of a ...

A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

Share on Pinterest Scientists are getting closer to accurately and quickly diagnosing chronic fatigue syndrome. Santi Nuñez/Stocksy There is no single test to diagnose chronic fatigue syndrome (CFS), ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. The first hints that Gregory Nelson might ...

Exact Sciences has launched its long-awaited blood test designed to detect the early stages of multiple tumors, with a plan to sell it to consumers through a telehealth program in a bid to increase ...

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear. This is the discovery of Mass General Brigham researchers who ...

Introduction: Multiple cytokines detection represents a more robust way to predict the disease progression than a single cytokine, and flow cytometry (FCM)-based assays are increasingly used worldwide ...